skip to main content

ACE inhibitor monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyCardiovascular TherapeuticsACE inhibitor monitoringGPhC CRA

A prescription for ramipril 2.5 mg daily is handed in for a 72-year-old woman with heart failure. Her PMR shows furosemide and spironolactone. Baseline U&Es were taken today. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Check renal function and potassium after starting and after dose changes

ACE inhibitors can reduce renal function and increase potassium, particularly with diuretics or mineralocorticoid receptor antagonists. U&Es should be checked before treatment and after initiation or dose changes. The other tests are not the key safety monitoring for ramipril in this scenario.

Reference: BNF; NICE CKS